{"id":"analogous-oseltamivir-phosphate-capsule","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Fatigue"},{"rate":"5-10%","effect":"Diarrhea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Oseltamivir carboxylate binds to the active site of neuraminidase, preventing the release of newly formed viral particles from infected cells. This action inhibits the spread of influenza virus within the body, thereby reducing the severity and duration of symptoms.","oneSentence":"Oseltamivir phosphate is a prodrug that is metabolized to oseltamivir carboxylate, which acts as a potent inhibitor of influenza virus neuraminidase.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:01:40.065Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment and prophylaxis of influenza A and B in patients 1 year and older"},{"name":"Treatment of acute uncomplicated influenza in patients 2 weeks of age and older"}]},"trialDetails":[{"nctId":"NCT02989012","phase":"PHASE2","title":"Phase IIaTrials of GanMaoKangNing Granules","status":"UNKNOWN","sponsor":"Dalian Zhen-Ao Bio-Tech Co., Ltd.","startDate":"","conditions":"Epidemic Influenza","enrollment":96},{"nctId":"NCT02662426","phase":"PHASE3","title":"Lingdancao Granules in the Treatment of Seasonal Influenza","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Guangzhou Medical University","startDate":"2016-04","conditions":"Influenza","enrollment":318}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["analogous oseltamivir phosphate capsule,0221503013"],"phase":"phase_3","status":"active","brandName":"analogous oseltamivir phosphate capsule","genericName":"analogous oseltamivir phosphate capsule","companyName":"The First Affiliated Hospital of Guangzhou Medical University","companyId":"the-first-affiliated-hospital-of-guangzhou-medical-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Oseltamivir phosphate is a prodrug that is metabolized to oseltamivir carboxylate, which acts as a potent inhibitor of influenza virus neuraminidase. Used for Treatment and prophylaxis of influenza A and B in patients 1 year and older, Treatment of acute uncomplicated influenza in patients 2 weeks of age and older.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}